Calendar Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Market Closed - Nyse 21:00:02 24/05/2024 BST 5-day change 1st Jan Change
217.2 USD -0.16% Intraday chart for Charles River Laboratories International, Inc. -1.99% -8.12%

Chart calendar Charles River Laboratories International, Inc.

929a3d.ZWK9da3EZYBjfW8b4VWgXk0aSP034--jqYba0-Paypc.VAroMv2DUdAaSDBOhiLKKAZ8fKdystn84LSf5YWO-_ZcWv4mnpsq0lEiGA~85cab5d39f91bd9615076d9a8e508fb3

Upcoming events on Charles River Laboratories International, Inc.

30/07/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)
11/02/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Charles River Laboratories International, Inc.

09/05/2024 13:30 Q1 2024 Earnings Call
09/05/2024 12:00 Q1 2024 Earnings Release
08/05/2024 13:00 Annual General Meeting
09/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:6181
09/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:5467
09/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:5315
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4703
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4413
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4224
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4191
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4186
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:4182
09/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:3975
08/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:2841
08/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:2840
08/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:2835
08/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:2714
08/04/2024 21:30 American Association for Cancer Research Meeting - Poster No:2630
08/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:2053
08/04/2024 17:00 American Association for Cancer Research Meeting - Poster No:2020

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
2 621
2 614
0.28%
2 924
2 891
1.15%
3 540
3 522
0.52%
3 976
3 915
1.56%
4 129
4 107
0.54%

4 221

EBITDA
Million USD
Released
Forecast
Spread
604
597
1.28%
701
693
1.26%
879
878
0.22%
991
982
0.87%
1 013
1 017
-0.4%

1 062

EBIT
Million USD
Released
Forecast
Spread
497
489
1.64%
585
575
1.73%
742
738
0.51%
834
820
1.67%
839
842
-0.35%

874

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
304
284
7.16%
447
394
13.45%
481
449
7.01%
623
568
9.63%
581
513
13.41%

534

Net income
Million USD
Released
Forecast
Spread
252
240
4.84%
364
296
23%
391
358
9.2%
486
409
18.85%
475
387
22.66%

406

EPS
USD
Released
Forecast
Spread
5,07
4,85
4.57%
7,20
5,88
22.44%
7,60
6,99
8.67%
9,48
7,97
18.98%
9,22
7,49
23.07%

7,91

Announcement Date11/02/2017/02/2116/02/2222/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
914
909
0.58%
973
995
-2.22%
989
970
1.93%
1 100
1 035
6.26%
1 029
986
4.39%
1 060
1 054
0.59%
1 027
1 000
2.61%
1 013
991
2.24%
1 012
993
1.82%

1 023


1 069


1 114


1 088


1 103

EBITDA
Million USD
Released
Forecast
Spread
233
233
0.02%
250
247
1.36%
240
238
1.14%
267
260
2.72%
260
252
3.03%
260
258
0.62%
255
241
5.8%
239
242
-1.38%
233
222
4.94%

244


283


304


263


273

EBIT
Million USD
Released
Forecast
Spread
196
194
1.26%
212
208
1.97%
201
197
2.26%
225
213
5.33%
218
209
3.98%
216
213
1.41%
211
194
8.51%
194
196
-1%
187
178
5.43%

197


235


254


224


233

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
111
149
-25.64%
144
142
1.83%
123
128
-3.67%
245
155
57.85%
131
150
-12.47%
129
143
-10.32%
113
120
-6.11%
209
120
74.62%
99,0
96,3
2.82%

110


156


169


150


157

Net income
Million USD
Released
Forecast
Spread
93,0
109
-14.63%
109
110
-0.34%
96,5
98,4
-1.95%
187
109
71.19%
103
102
0.7%
97,0
105
-7.26%
87,4
88,9
-1.74%
187
92,4
102.53%
67,3
71,2
-5.45%

89,4


115


131


109


119

EPS
USD
Released
Forecast
Spread
1,81
2,07
-12.39%
2,13
2,13
-0.04%
1,88
1,84
2.12%
3,65
2,14
70.86%
2,01
1,99
0.87%
1,89
2,04
-7.23%
1,69
1,68
0.51%
3,62
1,78
103.94%
1,30
1,35
-3.7%

1,73


2,25


2,56


2,08


2,26

Announcement Date04/05/2203/08/2202/11/2222/02/2311/05/2309/08/2308/11/2314/02/2409/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRL Stock
  4. Calendar Charles River Laboratories International, Inc.